Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
about
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Alterations of consciousness and mystical-type experiences after acute LSD in humans.Therapeutic infusions of ketamine: do the psychoactive effects matter?Clinical applications of hallucinogens: A review.The Importance of Terminal Values and Religious Experience of God's Presence and God's Absence in the Lives of University Students with Various Levels of Empathy.Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Phenomenology, Structure, and Dynamic of Psychedelic States.Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens.Long-term follow-up of psilocybin-facilitated smoking cessation.The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary PsychologyA sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Long-lasting subjective effects of LSD in normal subjects.Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016.The hidden therapist: evidence for a central role of music in psychedelic therapy.Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.Unifying Theories of Psychedelic Drug Effects.The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016).Congruence Between Near-Death and Mystical ExperienceDMT Models the Near-Death ExperiencePredicting Responses to Psychedelics: A Prospective Study
P2860
Q30833479-23E5F214-04DF-4A3B-AD85-C11A89FF1B5EQ30843010-7D4C84D6-AC82-4E1D-B61E-A93E8C107C96Q30847957-C05ED77C-8EA5-4E17-BF59-EC002EA99CADQ33880853-9650C726-CDF3-4F49-BA47-218A209AF020Q34535259-ECCB29C7-AEED-4E8F-9F73-A6DE6DD6131FQ35554835-43315FB8-4638-49D0-86F7-B7495B2A5FF5Q36999815-ADC54F26-B72E-4DAB-9A35-6ED16A37B64CQ37722650-857612AB-410E-47E0-9FE3-3571EBB6C064Q38351502-12D588E3-818C-4EE8-A8B5-53DD5C4FDB44Q38645170-6144EDB8-6D46-4371-AA95-5BEF085FA929Q39016513-638E5A54-9B04-4747-93CA-E5BAE0EEF072Q39057372-749C9DF1-6750-4B62-8531-C449C783CC37Q39237019-DEB815D5-001A-40BF-9980-C7CDFBC8C00BQ39548034-55859C51-F19E-47E8-9B39-50000EA54A2BQ39577435-6B0A0BF7-2861-49F7-BCD5-3F5DCCDF85AAQ42369129-A974471C-10E7-44DE-9811-EBDCE091EE2FQ47197626-20C6E48B-266A-427C-AE64-66933703BD44Q47550103-BF7405CE-195E-4196-AA8A-4FAF607CFC3FQ47691384-78D0A6D6-B3D5-4A6B-8DEF-42AB6E39BEDCQ48159644-9D30EF70-E891-4C89-AC99-9AB3EBCC63A7Q48314730-2011798D-8660-4634-9664-1A7FC1511D5CQ49357192-3AF39391-B53E-49D2-9339-DE4FCADB2F92Q50095081-32DACB96-B93E-4FAD-AB3D-4755A0C57AD6Q50109109-31121ED4-204E-4661-9B37-C77FC8475A8DQ52641641-E8EEB1B1-B029-4CDD-A6D2-13B5637C24E0Q53439351-1C827068-2C08-4251-83A0-71AEC434C457Q53439357-1BB0A558-844D-4149-B6A7-D4C403F52372Q53843342-BE6A03EF-B7A0-47E2-B38E-54DAC5105313Q54989656-82723CE7-6792-4783-A240-1DF80191FB0DQ56097236-CEF89516-0600-480F-A2AD-CAFA4AFEC50FQ59137436-2D24D9EF-4045-48A3-859F-380D811790DF
P2860
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Factor Analysis of the Mystica ...... by the Hallucinogen Psilocybin
@ast
Factor Analysis of the Mystica ...... by the Hallucinogen Psilocybin
@en
type
label
Factor Analysis of the Mystica ...... by the Hallucinogen Psilocybin
@ast
Factor Analysis of the Mystica ...... by the Hallucinogen Psilocybin
@en
prefLabel
Factor Analysis of the Mystica ...... by the Hallucinogen Psilocybin
@ast
Factor Analysis of the Mystica ...... by the Hallucinogen Psilocybin
@en
P2093
P2860
P1476
Factor Analysis of the Mystica ...... y the Hallucinogen Psilocybin.
@en
P2093
Jeannie-Marie S Leoutsakos
Katherine A Maclean
Matthew W Johnson
Roland R Griffiths
P2860
P304
P356
10.1111/J.1468-5906.2012.01685.X
P577
2012-12-01T00:00:00Z